NDC 67877-730 – Roflumilast

Roflumilast 250 ug/1 · Tablet · Oral

Human Prescription Drug

Product NDC67877-730

Product details

Brand name
Roflumilast
Generic name
Roflumilast
Labeler
Ascend Laboratories, LLC
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA212490
Marketed since
March 14, 2025
Listing expires
December 31, 2026
Pharmacologic class
Phosphodiesterase 4 Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Roflumilast →

Package NDC codes (5)

Package NDCDescriptionSince
67877-730-05500 TABLET in 1 BOTTLE (67877-730-05)Mar 14, 2025
67877-730-3030 TABLET in 1 BOTTLE (67877-730-30)Mar 14, 2025
67877-730-871 BLISTER PACK in 1 CARTON (67877-730-87) / 28 TABLET in 1 BLISTER PACKMar 14, 2025
67877-730-9090 TABLET in 1 BOTTLE (67877-730-90)Mar 14, 2025
67877-730-934 BLISTER PACK in 1 CARTON (67877-730-93) / 7 TABLET in 1 BLISTER PACK (67877-730-32)Mar 14, 2025

Other Roflumilast products